Nexalin Technology Inc. Common Stock NXL · Stock Open Nexalin Technology Inc. Common Stock in new tab
Nexalin Technology Inc. Common Stock Analysis (NXL)
Is Nexalin Technology Inc. Common Stock a good investment? Nexalin Technology Inc. Common Stock (NXL) is currently trading at 4.90 USD.
Earnings Schedule: Nexalin Technology Inc. Common Stock is expected to release its next earnings report on Dec. 2, 2026. The market consensus estimate for Forward EPS is -9.30.
Investor FAQ
Does Nexalin Technology Inc. Common Stock pay a dividend?
No, it does not currently pay a dividend.
What asset class is Nexalin Technology Inc. Common Stock?
Nexalin Technology Inc. Common Stock is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Dec. 2, 2026. The company currently has a trailing EPS of -13.80.
Company Profile
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
| Split Date | Split Ratio to 1 |
|---|---|
| Aug. 31, 2026 | 1:30 |
Community Discussion